How does COVID-19 impact treatment decision-making for clinicians in localised kidney cancer
BJUI Compass
.
2020 Nov 23;2(1):11-12.
doi: 10.1002/bco2.57.
eCollection 2021 Jan.
Authors
Katharina Beyer
1
,
Mieke Van Hemelrijck
1
,
Netty Kinsella
1
2
,
Ravi Barod
3
Affiliations
1
Translational Oncology and Urology Research (TOUR) King's College London London UK.
2
Department of Urology Royal Marsden Hospital London UK.
3
Specialist Centre for Kidney Cancer Royal Free Hospital London UK.
PMID:
33363288
PMCID:
PMC7753465
DOI:
10.1002/bco2.57
No abstract available